Singapore, May 26 -- Taiwan headquarteredBora Biologics, a leading contract development and manufacturing organization (CDMO) specialising in biologics manufacturing, has announced a major expansion of its US FDA-registered commercial manufacturing facility in San Diego, US.

This expansion will add state-of-the-art upstream and downstream GMP processing capabilities to meet the increasing demand for 2000L scale single-use biologics manufacturing, solidifying Bora Biologics' position as a premier biologics CDMO.

The expansion adds 8,075 square feet of state-of-the-art GMP manufacturing space to the San Diego biologics manufacturing facility, comprising a cutting-edge upstream mammalian cell culture hall, harvest suite with two inoculatio...